Route of Delivery Modulates the Efficacy of Mesenchymal Stem Cell Therapy for Myocardial Infarction A Meta-Analysis of Preclinical Studies and Clinical Trials

被引:142
作者
Kanelidis, Anthony J. [1 ]
Premer, Courtney [1 ,2 ]
Lopez, Juan [4 ]
Balkan, Wayne [1 ,3 ]
Hare, Joshua M. [1 ,3 ]
机构
[1] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Coral Gables, FL 33124 USA
[2] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Coral Gables, FL 33124 USA
[3] Univ Miami, Dept Med, Coral Gables, FL 33124 USA
[4] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA
基金
美国国家卫生研究院;
关键词
cell- and tissue-based therapy; heart failure; mesenchymal stem cell transplantation; meta-analysis; myocardial infarction; LEFT-VENTRICULAR FUNCTION; LARGE ANIMAL-MODELS; IMPROVES CARDIAC-FUNCTION; ISCHEMIC CARDIOMYOPATHY; PORCINE MODEL; TISSUE PERFUSION; HEME OXYGENASE-1; TRANSPLANTATION; HEART; INJECTION;
D O I
10.1161/CIRCRESAHA.116.309819
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Accumulating data support a therapeutic role for mesenchymal stem cell (MSC) therapy; however, there is no consensus on the optimal route of delivery. Objective: We tested the hypothesis that the route of MSC delivery influences the reduction in infarct size and improvement in left ventricular ejection fraction (LVEF). Methods and Results: We performed a meta-analysis investigating the effect of MSC therapy in acute myocardial infarction (AMI) and chronic ischemic cardiomyopathy preclinical studies (58 studies; n= 1165 mouse, rat, swine) which revealed a reduction in infarct size and improvement of LVEF in all animal models. Route of delivery was analyzed in AMI swine studies and clinical trials (6 clinical trials; n= 334 patients). In AMI swine studies, transendocardial stem cell injection reduced infarct size (n= 49, 9.4% reduction; 95% confidence interval, -15.9 to -3.0), whereas direct intramyocardial injection, intravenous infusion, and intracoronary infusion indicated no improvement. Similarly, transendocardial stem cell injection improved LVEF (n= 65, 9.1% increase; 95% confidence interval, 3.7 to 14.5), as did direct intramyocardial injection and intravenous infusion, whereas intracoronary infusion demonstrated no improvement. In humans, changes of LVEF paralleled these results, with transendocardial stem cell injection improving LVEF (n= 46, 7.0% increase; 95% confidence interval, 2.7 to 11.3), as did intravenous infusion, but again intracoronary infusion demonstrating no improvement. Conclusions: MSC therapy improves cardiac function in animal models of both AMI and chronic ischemic cardiomyopathy. The route of delivery seems to play a role in modulating the efficacy of MSC therapy in AMI swine studies and clinical trials, suggesting the superiority of transendocardial stem cell injection because of its reduction in infarct size and improvement of LVEF, which has important implications for the design of future studies.
引用
收藏
页码:1139 / +
页数:30
相关论文
共 50 条
  • [21] Safety and Efficacy of Adult Stem Cell Therapy for Acute Myocardial Infarction and Ischemic Heart Failure (SafeCell Heart): A Systematic Review and Meta-Analysis
    Lalu, Manoj M.
    Mazzarello, Sasha
    Zlepnig, Jennifer
    Dong, Yuan Yi
    Montroy, Joshua
    McIntyre, Lauralyn
    Devereaux, P. J.
    Stewart, Duncan J.
    David Mazer, C.
    Barron, Carly C.
    McIsaac, Daniel I.
    Fergusson, Dean A.
    [J]. STEM CELLS TRANSLATIONAL MEDICINE, 2018, 7 (12) : 857 - 866
  • [22] Efficacy of stem cell therapy for burn wounds: a systematic review and meta-analysis of preclinical studies
    Yuan Li
    Wei-dong Xia
    Leanne Van der Merwe
    Wen-tong Dai
    Cai Lin
    [J]. Stem Cell Research & Therapy, 11
  • [23] Efficacy of stem cell therapy for burn wounds: a systematic review and meta-analysis of preclinical studies
    Li, Yuan
    Xia, Wei-dong
    Van der Merwe, Leanne
    Dai, Wen-tong
    Lin, Cai
    [J]. STEM CELL RESEARCH & THERAPY, 2020, 11 (01)
  • [24] A Systematic Review and Meta-Analysis of Clinical Trials of Mesenchymal Stem Cell Therapy for Cartilage Repair
    Borakati, Aditya
    Mafi, Reza
    Mafi, Pouya
    Khan, Wasim S.
    [J]. CURRENT STEM CELL RESEARCH & THERAPY, 2018, 13 (03) : 215 - 225
  • [25] Preclinical efficacy of stem cell therapy for skin flap: a systematic review and meta-analysis
    Li, Yuan
    Jiang, Qi-lin
    Van der Merwe, Leanne
    Lou, Dong-hao
    Lin, Cai
    [J]. STEM CELL RESEARCH & THERAPY, 2021, 12 (01)
  • [26] Meta-Analysis of the Safety and Efficacy of Stem Cell Therapies for Ischemic Stroke in Preclinical and Clinical Studies
    Ouyang, Qian
    Li, Feng
    Xie, Yu
    Han, Jianbang
    Zhang, Zhongfei
    Feng, Zhiming
    Su, Dazhuang
    Zou, Xiaoxiong
    Cai, Yingqian
    Zou, Yuxi
    Tang, Yanping
    Jiang, Xiaodan
    [J]. STEM CELLS AND DEVELOPMENT, 2019, 28 (08) : 497 - 514
  • [27] Meta-Analysis of Cell Therapy Trials for Patients With Heart Failure
    Fisher, Sheila A.
    Doree, Carolyn
    Mathur, Anthony
    Martin-Rendon, Enca
    [J]. CIRCULATION RESEARCH, 2015, 116 (08) : 1361 - 1377
  • [28] Recent advances in mesenchymal stem cell therapy for myocardial infarction
    He, Yu-Chuan
    Yuan, Guo-Dong
    Li, Nan
    Ren, Mei-Fang
    Qian-Zhang
    Deng, Kai-Ning
    Wang, Le-Chuan
    Xiao, Wei-Ling
    Ma, Nan
    Stamm, Christof
    Felthaus, Oliver
    Prantl, Lukas
    Nie, Jia
    Wang, Gang
    [J]. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2024, 87 (03) : 383 - 398
  • [29] Evaluating the efficacy of mesenchymal stem cells for diabetic neuropathy: A systematic review and meta-analysis of preclinical studies
    Li, Yu
    Yue, Guangren
    Yu, Shuying
    Cheng, Xinhao
    Cao, Yilin
    Wang, Ximei
    [J]. FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2024, 12
  • [30] Bioactive Scaffolds in Stem Cell-Based Therapies for Myocardial Infarction: a Systematic Review and Meta-Analysis of Preclinical Trials
    Khan, Kashif
    Gasbarrino, Karina
    Mahmoud, Ibtisam
    Dufresne, Line
    Daskalopoulou, Stella S.
    Schwertani, Adel
    Cecere, Renzo
    [J]. STEM CELL REVIEWS AND REPORTS, 2022, 18 (06) : 2104 - 2136